Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
GLS protein | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
arylsulfatase A | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 9 | 0 | 9 |
Albumin | 0 | 0 | 1 | 1 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 1 | 0 | 3 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 3 |
Albumin | 0 | 1 | 1 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 4 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 4 |
UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 2 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
TDP1 protein | 5 | 0 | 0 | 5 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
AR protein | 7 | 0 | 0 | 7 |
Smad3 | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
progesterone receptor | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
estrogen nuclear receptor alpha | 8 | 0 | 0 | 8 |
polyprotein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
caspase-3 | 1 | 0 | 0 | 1 |
IDH1 | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
geminin | 6 | 0 | 0 | 6 |
Interferon beta | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 4 | 0 | 4 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
G | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 1 | 0 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 1 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 1 | 0 | 3 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 1 | 0 | 3 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 1 | 3 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |